Exact Mass: 560.3713
Exact Mass Matches: 560.3713
Found 58 metabolites which its exact mass value is equals to given mass value 560.3713,
within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error
8.0E-6 dalton.
Vitamin D3 glucosiduronate
6-[(3-{2-[7a-methyl-1-(6-methylheptan-2-yl)-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexyl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5Z,7R,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0)
(2S)-3-hydroxy-2-(octanoyloxy)propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
(2R)-2-hydroxy-3-(octanoyloxy)propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0)
(2S)-2-hydroxy-3-(octanoyloxy)propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,7Z,10R,11E,13Z,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0)
(2S)-3-hydroxy-2-(octanoyloxy)propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
(2R)-2-hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0)
(2S)-2-hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
2, 16, 18-Tri-Ac-(1alpha, 3beta, 11alpha)-Cholest-5-ene-2, 3, 16, 18-tetrol, 9CI
2, 16, 18-Tri-Ac-(1alpha, 3beta, 11alpha)-Cholest-5-ene-2, 3, 16, 18-tetrol, 9CI
Ecdysterone 2,3:20,22-diacetonide
20-Hydroxyecdysone 2,3:20,22-diacetonide
Origin: Plant; SubCategory_DNP: The sterols, Cholestanes
7, 15, 18-Tri-Ac-(3alpha, 7beta, 15beta)-Cholest-5-ene-3, 7, 15, 18-tetrol, 9CI
7, 15, 18-Tri-Ac-(3alpha, 7beta, 15beta)-Cholest-5-ene-3, 7, 15, 18-tetrol, 9CI
12alpha-acetoxy-16beta-(3-hydroxybutanoyloxy)-13beta,18beta-cyclobutan-20,24-dimethyl-24-oxoscalaran-25-ol
12alpha-acetoxy-16beta-(3-hydroxybutanoyloxy)-13beta,18beta-cyclobutan-20,24-dimethyl-24-oxoscalaran-25-ol
(E)-3beta-hydroxy-15beta-O-(beta-D-xylopyranosyl)-ergosta-5,22-dien-16-one|acanthifolioside A
(E)-3beta-hydroxy-15beta-O-(beta-D-xylopyranosyl)-ergosta-5,22-dien-16-one|acanthifolioside A
7alpha-acetoxy-21R?,23R?-epoxy-24S?,25-dihydroxy-21alpha-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|7alpha-acetoxy-21S?,23R?-epoxy-24S?,25-dihydroxy-21beta-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone I|brujavanone J
7alpha-acetoxy-21R?,23R?-epoxy-24S?,25-dihydroxy-21alpha-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|7alpha-acetoxy-21S?,23R?-epoxy-24S?,25-dihydroxy-21beta-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone I|brujavanone J
24-epi-pterosterone 2,3:20,22-diacetonide|24-epipterosterone-2,3,20,22-diacetonide
24-epi-pterosterone 2,3:20,22-diacetonide|24-epipterosterone-2,3,20,22-diacetonide
ajugasterone C 2,3;20,22-diacetonide|ajugasterone C-2,3,20,22-diacetonide
ajugasterone C 2,3;20,22-diacetonide|ajugasterone C-2,3,20,22-diacetonide
12alpha-acetoxy-16beta-(3R-hydroxybutanoyloxy)-20,24-dimethyl-24-oxoscalaran-25-al
12alpha-acetoxy-16beta-(3R-hydroxybutanoyloxy)-20,24-dimethyl-24-oxoscalaran-25-al
3alpha,22alpha-diacetoxy-20beta,21alpha,29-trihydrohy-30-norolean-12-ene
3alpha,22alpha-diacetoxy-20beta,21alpha,29-trihydrohy-30-norolean-12-ene
Cholcalciferyl-β-D-glucopyranosid-uronsaeure
6-[(3Z)-3-[(2E)-2-[7a-methyl-1-(6-methylheptan-2-yl)-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0)
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0)
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0)
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0)
3-acetyl-13-(acetyloxy)-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-hexadecahydrocyclobuta[i]chrysen-4-yl 3-hydroxybutanoate
3-acetyl-13-(acetyloxy)-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-hexadecahydrocyclobuta[i]chrysen-4-yl 3-hydroxybutanoate
(2r,3r,4s,5s)-2-[(1s,3as,3br,5as,9as,9bs,11as)-9a,11a-dimethyl-2,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-(acetyloxy)-2-hydroxy-4,5,6-trimethylheptan-3-yl acetate
(2r,3r,4s,5s)-2-[(1s,3as,3br,5as,9as,9bs,11as)-9a,11a-dimethyl-2,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-(acetyloxy)-2-hydroxy-4,5,6-trimethylheptan-3-yl acetate
methyl 10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
methyl 10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
14-hydroxy-17-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one
14-hydroxy-17-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one
(1r,2s,3s,4r)-1-[(1s,3's,3as,3br,5as,9as,9bs,11as)-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-4-hydroxy-2,3,4-trimethylpentyl acetate
(1r,2s,3s,4r)-1-[(1s,3's,3as,3br,5as,9as,9bs,11as)-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-4-hydroxy-2,3,4-trimethylpentyl acetate
(1s,2s,3s,4as,4br,6as,7s,10as,10br,12s,12as)-2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl (3r)-3-hydroxybutanoate
(1s,2s,3s,4as,4br,6as,7s,10as,10br,12s,12as)-2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl (3r)-3-hydroxybutanoate
methyl (1r,2s,4ar,4bs,6as,9r,10r,10as,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
methyl (1r,2s,4ar,4bs,6as,9r,10r,10as,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl 3-hydroxybutanoate
2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl 3-hydroxybutanoate
(3r,4ar,6ar,6bs,8ar,9r,10r,11s,12as,14ar,14br)-9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(3r,4ar,6ar,6bs,8ar,9r,10r,11s,12as,14ar,14br)-9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(1r,2r,4s,8r,10r,14s,17s,18r)-14-hydroxy-17-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one
(1r,2r,4s,8r,10r,14s,17s,18r)-14-hydroxy-17-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one
5-{3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-5-(acetyloxy)-2-hydroxy-2,3,4-trimethylpentyl acetate
5-{3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-5-(acetyloxy)-2-hydroxy-2,3,4-trimethylpentyl acetate
methyl (1s,2s,4as,4br,6as,9r,10r,10ar,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
methyl (1s,2s,4as,4br,6as,9r,10r,10ar,12as)-10-hydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-3,4,5,6,7,8,9,10a,12,12a-decahydro-2h-chrysene-6a-carboxylate
(2r,2as,3s,4s,5as,5br,7as,8s,11as,11br,13s,13as)-3-acetyl-13-(acetyloxy)-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-hexadecahydrocyclobuta[i]chrysen-4-yl (3s)-3-hydroxybutanoate
(2r,2as,3s,4s,5as,5br,7as,8s,11as,11br,13s,13as)-3-acetyl-13-(acetyloxy)-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-hexadecahydrocyclobuta[i]chrysen-4-yl (3s)-3-hydroxybutanoate
6-{9a,11a-dimethyl-2,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5-(acetyloxy)-6-hydroxy-2,3,4-trimethylheptan-2-yl acetate
6-{9a,11a-dimethyl-2,7-dioxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5-(acetyloxy)-6-hydroxy-2,3,4-trimethylheptan-2-yl acetate
(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate
(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate
1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one
1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one
5-(acetyloxy)-5-{2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate
5-(acetyloxy)-5-{2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate
9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
9-(acetyloxy)-10,11-dihydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate
(2s,3r,4s,5r,6r)-2-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14'r,16's)-16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-yl]-6-methyloxane-3,4,5-triol
(2s,3r,4s,5r,6r)-2-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14'r,16's)-16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-yl]-6-methyloxane-3,4,5-triol
(2s,3r,4r,4ar,6as,6br,8ar,10r,12ar,12br,14br)-10-(acetyloxy)-3-hydroxy-2-(hydroxymethyl)-2-methoxy-6a,6b,9,9,12a-pentamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picen-4-yl acetate
(2s,3r,4r,4ar,6as,6br,8ar,10r,12ar,12br,14br)-10-(acetyloxy)-3-hydroxy-2-(hydroxymethyl)-2-methoxy-6a,6b,9,9,12a-pentamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picen-4-yl acetate
(1r,3s,3as,3br,7s,9ar,9bs,11as)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one
(1r,3s,3as,3br,7s,9ar,9bs,11as)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-one
